Candriam S.C.A. increased its holdings in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 12.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 37,005 shares of the company's stock after purchasing an additional 4,231 shares during the period. Candriam S.C.A.'s holdings in Kimberly-Clark were worth $5,263,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Kimberly-Clark by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 35,235,465 shares of the company's stock worth $5,011,188,000 after purchasing an additional 92,920 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Kimberly-Clark by 6.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 11,264,013 shares of the company's stock worth $1,601,968,000 after purchasing an additional 674,046 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Kimberly-Clark by 5.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,529,108 shares of the company's stock worth $986,616,000 after purchasing an additional 417,118 shares during the period. Invesco Ltd. boosted its position in Kimberly-Clark by 3.1% during the 1st quarter. Invesco Ltd. now owns 5,827,666 shares of the company's stock worth $828,811,000 after purchasing an additional 173,915 shares during the period. Finally, Northern Trust Corp boosted its position in Kimberly-Clark by 12.6% during the 4th quarter. Northern Trust Corp now owns 3,974,239 shares of the company's stock worth $520,784,000 after purchasing an additional 445,552 shares during the period. 76.29% of the stock is owned by hedge funds and other institutional investors.
Kimberly-Clark Trading Down 0.2%
NYSE:KMB opened at $132.97 on Friday. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. Kimberly-Clark Co. has a one year low of $124.10 and a one year high of $150.45. The business's 50-day simple moving average is $130.38 and its 200 day simple moving average is $135.11. The stock has a market cap of $44.12 billion, a price-to-earnings ratio of 17.61, a price-to-earnings-growth ratio of 4.46 and a beta of 0.33.
Kimberly-Clark (NYSE:KMB - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.67 by $0.25. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The business had revenue of $4.16 billion for the quarter, compared to analysts' expectations of $4.85 billion. During the same quarter last year, the company posted $1.96 earnings per share. The company's quarterly revenue was down 1.6% compared to the same quarter last year. As a group, sell-side analysts predict that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.
Kimberly-Clark Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Stockholders of record on Friday, September 5th will be given a dividend of $1.26 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $5.04 annualized dividend and a dividend yield of 3.8%. Kimberly-Clark's dividend payout ratio (DPR) is presently 69.42%.
Analyst Ratings Changes
KMB has been the subject of a number of research reports. JPMorgan Chase & Co. raised shares of Kimberly-Clark from an "underweight" rating to a "neutral" rating and upped their price target for the stock from $125.00 to $138.00 in a research report on Monday, August 4th. Barclays upped their price objective on shares of Kimberly-Clark from $134.00 to $139.00 and gave the company an "equal weight" rating in a research report on Monday, August 4th. UBS Group dropped their target price on Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Wall Street Zen cut Kimberly-Clark from a "buy" rating to a "hold" rating in a research note on Thursday, April 24th. Finally, Piper Sandler started coverage on Kimberly-Clark in a research note on Friday, July 18th. They issued an "overweight" rating and a $144.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $142.70.
Get Our Latest Stock Report on KMB
Kimberly-Clark Company Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Further Reading
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.